Association of Myomectomy With Anti-Müllerian Hormone Levels and Ovarian Reserve

Devora Aharon, Lucky Sekhon, Chloe Getrajdman, MacKenzie Naert, William Hanley, Ahmad Kerr, Atoosa Ghofranian, Carlos Hernandez-Nieto, Joseph A. Lee, Alan Copperman, Charles Ascher-Walsh

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


OBJECTIVE:To assess whether open and minimally invasive myomectomy are associated with changes in postoperative ovarian reserve as measured by serum anti-müllerian hormone (AMH) level.METHODS:This prospective cohort study included patients who were undergoing open abdominal myomectomy that used a tourniquet or minimally invasive (robot-assisted or laparoscopic) myomectomy that used vasopressin. Serum AMH levels were collected before the procedure and at 2 weeks, 3 months, and 6 months after surgery. The mean change in AMH level at each postsurgery timepoint was compared with baseline. The effect of surgical route on the change in AMH level at each timepoint was assessed by using multivariable linear regression. A subanalysis evaluated postoperative changes in AMH levels among the open myomectomy and minimally invasive myomectomy groups individually.RESULTS:The study included 111 patients (mean age 37.9±4.7 years), of whom 65 underwent open myomectomy and 46 underwent minimally invasive myomectomy. Eighty-seven patients contributed follow-up data. Serum AMH levels declined significantly at 2 weeks postsurgery (mean change -0.30 ng/mL, 95% CI -0.48 to -0.120 ng/mL, P=.002). No difference was observed at 3 months or 6 months postsurgery. On multiple linear regression, open myomectomy was significantly associated with a decline in AMH level at 2 weeks postsurgery (open myomectomy vs minimally invasive myomectomy: β=-0.63±0.22 ng/mL, P=.007) but not at 3 months or 6 months. Subanalysis revealed a significant decline in mean serum AMH levels in the open myomectomy group at 2 weeks (mean change -0.46 ng/mL, 95% CI -0.69 to -0.25 ng/mL, P<.001) postsurgery but not at three or 6 months. In the minimally invasive myomectomy group, no significant differences in mean AMH levels were detected between baseline and any postoperative timepoint.CONCLUSION:Myomectomy is associated with a transient decline in AMH levels in the immediate postoperative period, particularly after open surgery in which a tourniquet is used. Anti-müllerian hormone levels returned to baseline by 3 months after surgery, indicating that myomectomy is not associated with a long-term effect on ovarian reserve, even with the use of a tourniquet to decrease blood loss.FUNDING SOURCE:This study was funded in part by a Roche Diagnostics Investigator-Initiated Study Grant.

Original languageEnglish
Pages (from-to)1000-1007
Number of pages8
JournalObstetrics and Gynecology
Issue number6
StatePublished - 1 Dec 2022


Dive into the research topics of 'Association of Myomectomy With Anti-Müllerian Hormone Levels and Ovarian Reserve'. Together they form a unique fingerprint.

Cite this